The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology
Annals of Neurology · 2025
DOI: 10.1002/ana.27204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Musung Keum und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Antihypertensive Agents, Hypertension, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Ministry of Science and ICT, South Korea, Seoul National University.
Themen: Demenz
Abstract (Originalsprache)
Objective
We investigated whether the use of antihypertensive medication (AHM) is associated with in vivo Alzheimer's Disease (AD) pathologies in older adults with hypertension and examined if the effect differs by drug‐class and blood–brain barrier (BBB) permeability of the drug.
Methods
This cross‐sectional study recruited participants from the Korean Brain Aging Study for the Early Diagnosis and Prevention of Alzheimer's Disease. Participants comprised both cognitively normal and impaired older adults diagnosed with hypertension (n = 408). All participants underwent comprehensive clinical assessment and [ 11 C] Pittsburgh Compound B positron emission tomography (PET) for measurement of cerebral β‐amyloid (Aβ) deposition. Additionally, a subset of participants (n = 120) was subjected to [ 18 F] AV‐1451 PET to assess tau deposition.
Results
The AHM group (n = 227) exhibited significantly lower Aβ deposition (B [SE] = −0.104 [0.037], p = 0.006) compared to the non‐AHM group (n = 181), even after controlling for age, sex, apolipoprotein E ε4‐positivity, vascular risk factors, and mean arterial blood pressure. Further analysis by AHM class showed an association between the use of renin‐angiotensin system inhibitors (RASi) and less Aβ deposition (B [SE] = −0.143[0.049], p = 0.004). No significant relationships were observed between the use of BBB‐permeable AHM and Aβ deposition. Additionally, associations between AHM use and tau deposition did not reach statistical significance.
Interpretation
Our findings suggest that AHM use may be associated with lower Aβ burden in older adults with hypertension. Further studies exploring the underlying mechanism, particularly related to RASi, may provide insights into new therapeutic targets for AD. ANN NEUROL 2025;97:1051–1061
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi, Republic of Korea.
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Convergence Research Center for Dementia, Seoul National University Medical Research Center, Seoul, Republic of Korea.
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
- Interdisciplinary Program of Cognitive Science, Seoul National University College of Humanities, Seoul, South Korea.
ORCID-Profile: Min Soo Byun, Joon Hyung Jung, Dong Young Lee
Förderung
- NIA NIH HHS
- Ministry of Science and ICT, South Korea
- Seoul National University
- Korea Dementia Research Center
- Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare
- Korea Health Industry Development Institute
- National Institute on Aging
Zitieren
APA
Keum, M., Byun, M. S., Yi, D., Ahn, H., Jung, G., Jung, J. H., Kong, N., Lee, J. Y., Kim, Y. K., Lee, Y. S., Kang, K. M., Sohn, C. H., Lee, D. Y., & KBASE Research Group (2025). The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology. Annals of Neurology. https://doi.org/10.1002/ana.27204
Vancouver
Keum M, Byun MS, Yi D, Ahn H, Jung G, Jung JH, et al. The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology. Annals of Neurology. 2025. doi:10.1002/ana.27204
BibTeX
@article{Keum2025,
author = {Keum, Musung and Byun, Min Soo and Yi, Dahyun and Ahn, Hyejin and Jung, Gijung and Jung, Joon Hyung and Kong, Nayeong and Lee, Jun-Young and Kim, Yu Kyeong and Lee, Yun-Sang and Kang, Koung Mi and Sohn, Chul-Ho and Lee, Dong Young and KBASE Research Group, KBASE Research Group},
title = {The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology},
journal = {Annals of Neurology},
year = {2025},
doi = {10.1002/ana.27204}
}
EUVIMED